'Therapeutic agents' diaporamas de présentation

LECTURE (2) COMPOSITION OF PARENTERALS

LECTURE (2) COMPOSITION OF PARENTERALS. (VEHICALS AND ADDED SUBSTANCES). I. VEHICLES FOR INJECTIONS: 1 . Aqueous Vehicles:. 1-WATER FOR INJECTION: Most frequently used for parenteral formulation Purified water underwent distillation or reverse osmosis

909 views • 63 slides

COLLOIDS

COLLOIDS. Dispersed Systems:. Dispersed systems consist of particulate matter (dispersed phase), distributed throughout a continuous phase (dispersion medium). They are classified according to the particle diameter of the dispersed material: 1- Molecular dispersions (less than 1 nm)

1.76k views • 59 slides

861 views • 55 slides

Preterm Birth

Preterm Birth. Present by: Dr.Worapa Asavaritikrai Health Promotion Center Region 4. Objective. Definition Risk factors Diagnosis Treatment. Definition of Preterm Birth. A birth that occurs before 37 completed w ee ks of gestation (<259 days)

1.18k views • 44 slides

The Medical Home Model: Case Management Perspectives

440 views • 33 slides

Sirtris Pharmaceuticals: Living healthier, longer

John Burr Ph.D. Sirtris Pharmaceuticals: Living healthier, longer. Warm-up Question 1. 1. According to www.wineinstitute.org , which of the following countries has the highest wine consumption per capita in 2008? A. Switzerland B. United States C. Spain D. United Kingdom.

853 views • 31 slides

Neurodegenerative Disease

Neurodegenerative Disease. Dr Melvyn A Sydney-Smith. KGSJ. MBBS, PhD, Dip Gest Ther, Master Prac NLP, FACNEM. Australian College of Holistic Medicine Adjunct Professor, Nutrition Medicine RMIT University. Neurodegenerative Disease.

1.4k views • 22 slides

A P Attanayake , K A P W Jayatilake , C Pathirana , L K B Mudduwa

Influence of three medicinal plant extracts on lipid peroxidation in streptozotocin induced diabetic rats. A P Attanayake , K A P W Jayatilake , C Pathirana , L K B Mudduwa Faculty of Medicine, University of Ruhuna .

359 views • 20 slides

Jade Buchanan-Carter Aaron Buechlein Leo Senderowicz School of Informatics

325 views • 19 slides

A Promising Chemotherapy Agent, Gd@C82(OH)22

A Promising Chemotherapy Agent, Gd@C82(OH)22. Ning Zhang Tianjin Medical University Cancer Institute and Hospital UICC 2008. Chemotherapies have always been accompanied with serious side effects. Can nanoparticles provide a new approach to design low toxic therapeutic agents?.

274 views • 16 slides

Signaling Pathways Produced By Combining DsRNA with Paclitaxal to treat Ovarian Cancer

Signaling Pathways Produced By Combining DsRNA with Paclitaxal to treat Ovarian Cancer. Switu Patel. Ovarian Cancer. Fifth in, malignant deaths of US women Cause unknown Common Therapy: surgery + chemotherapy. Dual treatments.

278 views • 15 slides

NANOTECHNOLOGY IN THE FIELD OF MEDICINE

NANOTECHNOLOGY IN THE FIELD OF MEDICINE. Abdulrahman Alfawaz. NANo ?. Nano is derived from ? ? ?o? , the Greek word for dwarf U sually is combined with a noun to form words such as nanometer, nanotechnology or nanorobot . TITUS L. SCHLEYER. HOW SMALL IS NANO?.

410 views • 14 slides

Injectable Drug Delivery Market: Global Industry Analysis

271 views • 6 slides

CLINICAL TRIALS IN RETT SYNDROME A Mini-Symposium Chicago, June 22-23, 2008

CLINICAL TRIALS IN RETT SYNDROME A Mini-Symposium Chicago, June 22-23, 2008. Organized by: RettSearch Sponsored by: International Rett Syndrome Foundation. CLINICAL TRIALS IN RETT SYNDROME A Mini-Symposium Chicago, June 22-23, 2008. CONTEXT.

227 views • 4 slides

134 views • 3 slides

Materials World Network: Structure-response relations of advanced diagnostic tools Judy S. Riffle, Virginia Polytechnic Institute and State University, DMR 0909065.

160 views • 2 slides

Engineering Theranostic Nanovehicles to Target Cerebrovascular Amyloid

Engineering Theranostic Nanovehicles to Target Cerebrovascular Amyloid E . Agyare 1 ; K.M. Jaruszewski 2 ; G.L. Curran 3 ; J.T. Rosenberg 4 ; S.C. Grant 4 ; V.J. Lowe 3 ; S. Ramakrishnan 4 ; Paravastu 4 ; J.F. Poduslo 3 ; K.K. Kamdimalla 2

254 views • 2 slides